US Patent 10086049 Conjugates of somatostatin analogues

Patent 10086049 was granted and assigned to ProLynx on October, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10086049

Patent Inventor Names

Gary W. Ashley0

Brian Hearn0

Daniel V. Santi0

Eric L. Schneider0

Date of Patent

October 2, 2018

Patent Application Number

15030353

Date Filed

October 22, 2014

Patent Primary Examiner

‌

Thomas S Heard

Patent abstract

Conjugates of carriers and hydrogels for controlling the biological half-life of somatostatin and its analogs are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10086049 Conjugates of somatostatin analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API